Typicality: | 0.455 |
Saliency: | 0.686 |
for treatment of separation anxiety | 7 | purpose |
in the us | 4 | location |
in december | 2 | temporal |
fluoxetine → be approved by → the fda | 12 |
fluoxetine → be approved for → use | 4 |
fluoxetine → be → approved | 4 |
fluoxetine → be → fda-approved | 3 |
fluoxetine → be approved by → the food and drug administration | 3 |
negative | neutral | positive |
0.048 | 0.466 | 0.486 |
Raw frequency | 26 |
Normalized frequency | 0.686 |
Modifier score | 0.500 |
Perplexity | 12.797 |